Evolent Health, Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2015 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Evolent Health, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2015 to Q3 2024.
  • Evolent Health, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $22.2M, a 6.72% decline year-over-year.
  • Evolent Health, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $88.3M, a 10.7% increase year-over-year.
  • Evolent Health, Inc. annual Amortization of Intangible Assets for 2023 was $91M, a 159% increase from 2022.
  • Evolent Health, Inc. annual Amortization of Intangible Assets for 2022 was $35.2M, a 19.7% increase from 2021.
  • Evolent Health, Inc. annual Amortization of Intangible Assets for 2021 was $29.4M, a 8.98% decline from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $88.3M $22.2M -$1.6M -6.72% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $89.9M $22M -$2M -8.33% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $91.9M $22M +$900K +4.27% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $91M $22.1M +$11.2M +103% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 $79.8M $23.8M +$14.3M +151% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $65.5M $24M +$16.7M +229% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $48.8M $21.1M +$13.6M +181% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $35.2M $10.9M +$3.6M +49.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $31.6M $9.5M +$2.1M +28.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $29.5M $7.3M +$100K +1.39% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $29.4M $7.5M $0 0% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $29.4M $7.3M -$100K -1.35% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $29.5M $7.4M +$200K +2.78% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $29.3M $7.2M -$1.2M -14.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $30.5M $7.5M -$1.8M -19.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $32.3M $7.4M -$1.6M -17.8% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $33.9M $7.2M -$2.2M -23.4% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $36.1M $8.4M -$1.2M -12.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $37.3M $9.3M +$200K +2.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $37.1M $9M -$200K -2.17% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-24
Q3 2019 $37.3M $9.4M +$3.3M +54.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $34M $9.6M +$3.6M +60% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $30.4M $9.1M +$3.2M +54.2% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $27.2M $9.2M +$1.4M +17.9% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $25.8M $6.1M +$800K +15.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-05
Q2 2018 $25M $6M +$1.1M +22.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $23.9M $5.9M +$1.1M +22.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $22.8M $7.8M +$3.2M +69.6% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $19.6M $5.3M +$2.6M +96.3% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $17M $4.9M +$2.3M +88.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $14.7M $4.8M +$2.2M +84.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $12.5M $4.6M +$2.1M +84% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $10.4M $2.7M +$200K +8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $10.2M $2.6M +$1.8M +225% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $8.4M $2.6M +$2.6M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $5.8M $2.5M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 $2.5M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $800K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $0 Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.